Article Details

Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at ...

Retrieved on: 2022-11-21 08:44:21

Tags for this article:

Click the tags to see associated articles and topics

Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at .... View article details on hiswai:

Excerpt

Millennium Management LLC now owns 50,748 shares of the biopharmaceutical company's stock valued at $35,000 after acquiring an additional 40,003 ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up